NCT06712108 is a clinical trial of tranplant in Adult Double Unit Cord Blood Transplant, sponsored by Seoul National University Hospital.

Who is sponsoring NCT06712108?

NCT06712108 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT06712108?

Interventions in NCT06712108: tranplant.

What condition does NCT06712108 study?

NCT06712108 studies Adult Double Unit Cord Blood Transplant.

Is NCT06712108 still recruiting?

NCT06712108 is currently recruiting now. Last updated 2 February 2026.

Last reviewed 2026-02-02 · How we verify

NCT06712108

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Double Unit Cord Blood Transplant in Hematologic Malignancies.

Recruiting now Last updated 2 February 2026

What this trial tests

trial testing tranplant in Adult Double Unit Cord Blood Transplant in 40 participants. Currently enrolling.

Timeline

21 December 2023

Primary endpoint
31 March 2030

31 March 2030

Quick facts

Lead sponsor	Seoul National University Hospital
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	40
Start date	21 December 2023
Primary completion	31 March 2030
Estimated completion	31 March 2030
Sites	6 locations across South Korea

Drugs / interventions tested

tranplant

Conditions studied

Adult Double Unit Cord Blood Transplant — all drugs for Adult Double Unit Cord Blood Transplant →

Sponsor

Seoul National University Hospital

Who can join

19 and older, any sex, with Adult Double Unit Cord Blood Transplant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The efficacy and safety of non-myeloablative and myeloablative preconditioning followed by dual-unit umbilical cord blood transplantation from unrelated donors in adult patients with malignant hematologic diseases eligible for allogeneic hematopoietic stem cell transplantation are evaluated through prospective observation and analysis of actual clinical data collection

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06712108 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 2 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06712108.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing